Disease model: familial adenomatous polyposis

被引:69
作者
Fodde, R [1 ]
Smits, R [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Human & Clin Genet, Sylvius Labs, NL-2333 AL Leiden, Netherlands
关键词
D O I
10.1016/S1471-4914(01)02050-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the APC gene are responsible for familial adenomatous polyposis (FAP) and for the majority of sporadic colorectal cancers. The establishment of genotype-phenotype correlations in FAP is often complicated by the great clinical variability observed among carriers of the same APC mutation even within the same kindred. This variability is likely to arise from the interaction of genetic and environmental modifying factors, the dissection of which ideally requires the employment of mouse models where the effects of specific Apc mutations are analyzed in an inbred, homogeneous genetic background and a controlled environment. The availability of different Apc mouse models allows not only the establishment of more precise genotype-phenotype correlations but has also provided very important clues for the understanding of the function of APC in homeostasis and tumorigenesis. Also, the close phenotypic resemblance to the human disease makes these mice unique preclinical models to test chemopreventive and therapeutic interventions.
引用
收藏
页码:369 / 373
页数:5
相关论文
共 68 条
  • [1] Baker SM, 1998, CANCER RES, V58, P1087
  • [2] Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin
    Barnes, CJ
    Lee, M
    [J]. GASTROENTEROLOGY, 1998, 114 (05) : 873 - 877
  • [3] Linking colorectal cancer to Wnt signaling
    Bienz, M
    Clevers, H
    [J]. CELL, 2000, 103 (02) : 311 - 320
  • [4] BUSSY HJR, 1975, FAMILIAL ADENOMATOUS
  • [5] Chiu CH, 1997, CANCER RES, V57, P4267
  • [6] Discordant effect of aspirin and indomethacin on intestinal tumor burden in ApcMin/+ mice
    Chiu, CH
    McEntee, MF
    Whelan, J
    [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2000, 62 (05): : 269 - 275
  • [7] Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile
    Churchill, M
    Chadburn, A
    Bilinski, RT
    Bertagnolli, MM
    [J]. JOURNAL OF SURGICAL RESEARCH, 2000, 89 (02) : 169 - 175
  • [8] CLARKE AR, 1995, ONCOGENE, V11, P1913
  • [9] Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis
    Cormier, RT
    Hong, KH
    Halberg, RB
    Hawkins, TL
    Richardson, P
    Mulherkar, R
    Dove, WF
    Lander, ES
    [J]. NATURE GENETICS, 1997, 17 (01) : 88 - 91
  • [10] de Wind N, 1998, CANCER RES, V58, P248